Section

AstraZeneca cancer drug Enhertu show encouraging initial results for other tumors

2 years ago Philippines inquirer

A PHP Error was encountered

Severity: Warning

Message: getimagesize(https://newsinfo.inquirer.net/files/2023/03/2023-03-06T073440Z_1_LYNXMPEJ25066_RTROPTP_4_ASTRAZENECA-CANCER-EU-300x230.jpg): Failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden

Filename: views/amp_news_detail.php

Line Number: 138

Backtrace:

File: /home/moneynations/public_html/application/views/amp_news_detail.php
Line: 138
Function: getimagesize

File: /home/moneynations/public_html/application/controllers/News.php
Line: 132
Function: view

File: /home/moneynations/public_html/index.php
Line: 291
Function: require_once

AstraZeneca said Monday that a mid-stage trial of its cancer drug Enhertu, co-developed with Daiichi Sankyo, showed positive results across multiple HER2-expressing advanced solid tumors in heavily pre-treated patients. The ongoing DESTINY-PanTumor02 Phase II trial is assessing the efficacy and safety of Enhertu in patients with locally advanced or metastatic previously treated solid tumors that […]

The post AstraZeneca cancer drug Enhertu show encouraging initial results for other tumors appeared first on Inquirer News.

Read more at: inquirer

Tags : astrazeneca cancer enhertu encouraging initial results other tumors

Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Bollywood charcha does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.

You May Also Like